A Beacon of Hope and a Stock Market Phenomenon: The Capricor Therapeutics Story

The FDA's Bold New Vision: Could One Clinical Trial Be Enough for Drug Approval?

The Unforeseen Hope: Ozempic's Astonishing Link to Alzheimer's

An Unprecedented Outcry: 12 Former FDA Chiefs Lambaste Agency Memo on Vaccines, Calling It "Deeply Stupid"

ADC Therapeutics Shares Face Brutal Sell-Off After Disappointing Clinical Trial Results

The Enduring Quest: Semaglutide and the Unyielding Challenge of Alzheimer's

Pharma's Unfolding Drama: 340B Clashes, Vaccine Progress, and Cancer Innovation

Shattuck Labs Takes Flight: Goldman Sachs' Bold 'Buy' Rating Ignites Biotech Stock

A Glimmer of Hope: India's Indigenous Cancer Vaccine Plea Heads to High Court Scrutiny

AI Drug Discovery Takes a Giant Leap: Iambic Therapeutics Secures $100M

A Glimmer of Hope: Scientists Uncover Potential Type 1 Diabetes Cure in Landmark Study

CureVac's Crossroads: Why Wall Street Is Treading Carefully Towards 2026

A Vital Step Forward: Sarepta's Duchenne Drug Secures Key Testing Clearance

Kala Bio's Overnight Leap: Unpacking the Nearly 38% Stock Rocket

A Glimmer of Hope: Novo Nordisk's Next-Gen Drug Shows Remarkable Promise in Battling Obesity and Diabetes

The CAR-T Paradox: Why Arcellx Shares Tumbled Despite 100% Response Rate

A Glitch in the Hope: Ozempic's Oral Sibling Fails to Deliver in Alzheimer's Trials

The Unfolding Saga of GLP-1 Drugs: A Potential Game-Changer for Alzheimer's?

A New Dawn: Why This Lung Cancer Drug Has Scientists (and Patients) Buzzing

The Quiet Resurgence: Can a Centuries-Old Herb Rewrite the Script for Alzheimer's?

A Glimmer of Hope: Unpacking AMT-253's Early Promise Against Metastatic Melanoma

Beyond the Horizon: Can Survodirsen Rewrite the Future for NASH Cirrhosis?

The Unseen Battle: How Komzifti is Redrawing the Lines in Leukemia's Long War

AnaptysBio's Big Bet: Decoding the ANB033 Play in the High-Stakes World of Rheumatoid Arthritis

The Unseen Hurdles: Intellia's Gene-Editing Dream Hits a Safety Snag

The Shifting Sands of Biotech: What Analysts Really Think of Bicycle Therapeutics

Unpacking Biopharma's Wild Ride: Fast Money's Hot Takes on Navigating the Next Wave

A New Dawn for Hepatitis B? Brii Biosciences Unveils Promising Cure Data

Cabaletta Bio's Q3 Unveils a Story of Progress and Promise in Autoimmune Therapies

The Biotech Crossroads: Where Vor Biopharma and Liminatus Pharma Stand in the Race for Innovation

A Bold New Chapter: Yale Takes On Metastatic Breast Cancer with Innovative Trials

Immunome's Latest Financial Dive: More Than Just Numbers on a Page

When Biotech Promises Falter: The Atyr Pharma Story and a Quest for Investor Justice

Beyond the Benchtop: The Human Heartbeat of Kidney Week 2025's Breakthroughs

Immunocore at the Crossroads: Steady Hands and the Search for Tomorrow's Breakthrough

Cellectis Charts Its Course: A Biotech Journey Through Research, Finances, and Hope

The Quiet Roar of Progress: Unpacking Silence Therapeutics' Latest Chapter

The FDA's Tightening Grip: A Crucible for Biotech's Biggest Bets

Beyond the Horizon: How Compugen's COM701 is Quietly Redefining the Battle Against Cancer